SC 13D Filing

Company

Theriva Biologics, Inc.

Filed

October 9, 2008

Accession Number

0000950159-08-001403

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →